Peptides/Thymosin Alpha-1

Thymosin Alpha-1

research

Immune-modulating peptide that enhances T-cell function and overall immune defence

Thymic peptide
Type
SC injection
Route
Yes — vendors & clinics
Available in Thailand
Yes — select clinics
Clinic therapy

Availability in Thailand

Thymosin Alpha-1 is available from Thai peptide vendors and offered at several clinics in Bangkok specialising in immune support and longevity programs. It has regulatory approval in over 30 countries under the brand name Zadaxin, giving it stronger safety credentials than most research peptides.

Prescription: Not required from peptide vendors. Clinics may include it in supervised immune protocols.

Legal status: Approved as a pharmaceutical in 30+ countries. Available as a research peptide in Thailand.

Where to Buy in Thailand

Thymosin alpha-1 pricing varies by vendor and vial size. Check vendor and clinic websites for current rates.

Vendors

Synergy Peptides

Bangkok

Premium GMP-certified peptides with verified COAs

View vendor →

Clinics

FRESH GENETIQ

Bangkok

Immune support and longevity programs

View clinic →

Miskawaan Health Group

Bangkok

Integrative medicine and immune protocols

View clinic →

Phuket Family Health

Phuket

Phuket-based clinic with peptide telehealth services

View clinic →

Overview

Thymosin Alpha-1 is a 28-amino acid peptide naturally produced by the thymus gland, the organ responsible for training and maturing T-cells — the immune system's primary defence force. It enhances the body's immune response by boosting T-cell production and function, activating natural killer cells, and modulating the balance between immune activation and suppression. It has been approved as a therapeutic agent in several countries for hepatitis B and C treatment.

How It Works

T-cell maturation and activation

Thymosin alpha-1 promotes the maturation of thymocytes (immature immune cells) into fully functional T-cells. It activates both helper T-cells (CD4+) and cytotoxic T-cells (CD8+), strengthening the adaptive immune response against infections and abnormal cells.

Natural killer cell activation

Enhances the activity of natural killer (NK) cells, which are part of the innate immune system and serve as the body's first line of defence against viral infections and tumour cells.

Dendritic cell stimulation

Activates dendritic cells — the immune system's 'scouts' — improving the body's ability to detect and respond to pathogens. Also enhances vaccine efficacy by improving the antigen presentation process.

Immune balance modulation

Rather than simply boosting immune activity, thymosin alpha-1 helps balance the immune response — reducing excessive inflammation while enhancing targeted immune activity. This makes it useful in both immune deficiency and autoimmune contexts.

Protocol Quick Reference

starting Dose
1.6 mg 2-3 times per week
maintenance Dose
1.6 mg 2-3 times per week (some protocols use daily dosing for acute immune support)
escalation
Not typically escalated — standard dose from the start
injection Sites
Subcutaneous — abdomen or upper arm
full Titration
Not applicable — consistent dosing from start
cycle Length
4-12 weeks for immune support cycles. Can be used longer-term under medical supervision
storage
Refrigerated 2-8°C after reconstitution
reconstitution
Reconstitute lyophilised powder with bacteriostatic water
timing
Any consistent time. Some practitioners recommend morning dosing to align with natural immune circadian rhythms
special Notes
One of the few peptides with regulatory approval in multiple countries (under the brand name Zadaxin). Often used alongside other immune-supporting peptides like LL-37 or as an adjunct to standard medical treatment.

Benefits & Uses

  • Enhanced immune defence: Strengthens overall immune function by activating T-cells, NK cells, and dendritic cells
  • Anti-viral properties: Has been studied extensively for hepatitis B and C, and gained attention for potential benefits against respiratory infections
  • Vaccine enhancement: Can improve the body's response to vaccines, making them more effective
  • Infection prevention: Used by some practitioners as prophylactic immune support, particularly in immunocompromised individuals or during travel
  • Anti-tumour support: Research suggests potential as an adjunct in cancer treatment by enhancing immune surveillance against tumour cells
  • Approved in multiple countries: Unlike most research peptides, thymosin alpha-1 has regulatory approval in over 30 countries for hepatitis treatment

Side Effects

Common

  • Injection site redness or mild irritation
  • Mild fatigue — typically transient
  • Mild flu-like symptoms during initial use (actually a sign of immune activation)

Less Common

  • Headache
  • Muscle aches
  • Low-grade fever

Serious

  • Generally well-tolerated with an extensive safety record from clinical use in 30+ countries
  • Caution in autoimmune conditions — while it modulates rather than simply stimulates immunity, discuss with a healthcare provider
  • Not recommended for organ transplant recipients on immunosuppressive therapy

Related Peptides

FAQ

Is thymosin alpha-1 an approved medication?

Yes — unlike most peptides on this site, thymosin alpha-1 has regulatory approval in over 30 countries (primarily in Asia and South America) under the brand name Zadaxin, primarily for hepatitis B and C treatment. In Thailand, it is accessible as a research peptide through vendors and clinics.

Can thymosin alpha-1 help prevent infections?

Research suggests it enhances overall immune function, which may help the body fight infections more effectively. Some practitioners use it as prophylactic immune support during travel or for immunocompromised individuals. It has also been shown to improve vaccine response.

Is thymosin alpha-1 safe for long-term use?

It has one of the strongest safety records among research peptides, given its history of clinical use in 30+ countries. Long-term use appears well-tolerated, though it should be used under medical supervision, particularly for individuals with autoimmune conditions.

How does thymosin alpha-1 differ from thymosin beta-4 (TB-500)?

They are both thymosin family peptides but have completely different functions. Thymosin alpha-1 modulates the immune system by enhancing T-cell function and immune defence. TB-500 promotes tissue repair and healing through actin regulation and cell migration. Different goals, different peptides.

Disclaimer

This information is for educational purposes only and does not constitute medical advice. Peptides should be used under the guidance of a qualified healthcare professional. Individual results vary. Always consult your doctor before starting any peptide therapy.